Literature DB >> 1598660

Long-term follow-up of 92 patients with locally advanced follicular or papillary thyroid cancer after combined treatment.

C Glanzmann1, U M Lütolf.   

Abstract

Between 1960 and 1988, 92 patients with a locally advanced follicular or papillary thyroid cancer have been treated with surgery and radiotherapy consisting of iodine-131 or external (ext RT) radiotherapy or both. Locoregional control in patients less than 38 years of age at diagnosis and in older patients with a papillary cancer and a macroscopically complete resection was 100% with or without ext RT. Locoregional control in patients 38 years of age or older and without palpable postsurgical residual mass was 89% with ext RT and 60% without. In patients with a palpable residual mass, one of ten treated with iodine-131 alone had a permanent local control compared to six of 14 treated with addition of ext RT. Published data concerning iodine-131 and ext RT in the treatment of locally advanced follicular or papillary thyroid cancer are discussed. Routine surgery in our region consists of a near total thyroid resection, followed by iodine-131 ablation of the remnant thyroid. In younger patients with a limited T4 tumour and complete resection, we do not use ext RT. In all older patients with a T4 tumour as well as in younger patients with an extensive T4 tumour, ext RT is added.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1598660

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  3 in total

1.  [The treatment of thyroid carcinomas: the results of a prospective multicenter study].

Authors:  T Kuwert
Journal:  Strahlenther Onkol       Date:  1999-04       Impact factor: 3.621

Review 2.  An evidence-based review of poorly differentiated thyroid cancer.

Authors:  Enoch M Sanders; Virginia A LiVolsi; James Brierley; Jennifer Shin; Gregory W Randolph
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

3.  [Prognostic factors and the effect of radiotherapy in the treatment of differentiated thyroid carcinomas].

Authors:  I A Adamietz; M S Schiemann; J G Petkauskas; F Schemmann; H D Böttcher
Journal:  Strahlenther Onkol       Date:  1998-12       Impact factor: 3.621

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.